BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
62 results:

  • 1. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Central Nervous System Tumor With bcl6 Corepressor Internal Tandem Duplication: treatment Course of a Long-term Survivor.
    Bakkar M; Altinok D; Kupsky WJ; Marupudi NI; Chiang J; Gorsi HS
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):352-355. PubMed ID: 37314948
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
    van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
    Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood cancer Survivor Study.
    Hesko C; Liu W; Srivastava DK; Brinkman TM; Diller L; Gibson TM; Oeffinger KC; Leisenring WM; Howell R; Armstrong GT; Krull KR; Henderson TO
    Cancer; 2023 Sep; 129(18):2904-2914. PubMed ID: 37199722
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The potential bioactive ingredients and hub genes of five TCM prescriptions against lung adenocarcinoma were explored based on bioinformatics.
    Liu T; Wei J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2039-2055. PubMed ID: 36914901
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Health Care Utilization and Medical Costs in Long-Term Follow-Up of Children Diagnosed With Leukemia, Solid Tumor, or brain Tumor: Population-Based Study Using the National Health Insurance Claims Data.
    Miser JS; Shia BC; Kao YW; Liu YL; Chen SY; Ho WL
    JMIR Public Health Surveill; 2023 Mar; 9():e42350. PubMed ID: 36862495
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Do animal models of brain tumors replicate human peritumoral edema? a systematic literature search.
    Schramm MWJ; Currie S; Lee MT; Livermore LJ; Solanki SP; Mathew RK; Wurdak H; Lorger M; Twelves C; Short SC; Chakrabarty A; Chumas P
    J Neurooncol; 2023 Feb; 161(3):451-467. PubMed ID: 36757526
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B-cell Lymphoma 6 (bcl6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric cancers.
    McLachlan T; Matthews WC; Jackson ER; Staudt DE; Douglas AM; Findlay IJ; Persson ML; Duchatel RJ; Mannan A; Germon ZP; Dun MD
    Mol Cancer Res; 2022 Dec; 20(12):1711-1723. PubMed ID: 36166198
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine.
    Fan H; Xie X; Kuang X; Du J; Peng F
    Am J Chin Med; 2022; 50(7):1799-1825. PubMed ID: 36121713
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
    Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
    World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of a Three-Drug Regimen Containing Bevacizumab for the treatment of Recurrent Pediatric
    Chen Z; Tian F; Chen X
    Front Public Health; 2022; 10():914536. PubMed ID: 35719637
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for cancer and treatment [ProtecT] study).
    Lane JA; Donovan JL; Young GJ; Davis M; Walsh EI; Avery KNL; Blazeby JM; Mason MD; Martin RM; Peters TJ; Turner EL; Wade J; Bollina P; Catto JWF; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Neal DE; Hamdy FC; Metcalfe C;
    BJU Int; 2022 Sep; 130(3):370-380. PubMed ID: 35373443
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.
    Di W; Fan W; Wu F; Shi Z; Wang Z; Yu M; Zhai Y; Chang Y; Pan C; Li G; Kahlert UD; Zhang W
    Cancer Sci; 2022 Feb; 113(2):756-769. PubMed ID: 34881489
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. History of atopy confers improved outcomes in IDH mutant and wildtype lower grade gliomas.
    Jaman E; Zhang X; Sandlesh P; Habib A; Allen J; Saraiya RG; Amankulor NM; Zinn PO
    J Neurooncol; 2021 Nov; 155(2):133-141. PubMed ID: 34714520
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Case Report: Identification of Potential Prognosis-Related
    Zhang Y; Ma L; Liu J; Zhu H; Lu L; Deng K; Ma W; Pan H; Wang R; Yao Y
    Front Endocrinol (Lausanne); 2021; 12():673908. PubMed ID: 34381423
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer.
    Yu H; Chen P; Cai X; Chen C; Zhang X; He L; Zhou Y; Hong S; Zhang B
    Cancer Immunol Immunother; 2022 Mar; 71(3):637-644. PubMed ID: 34297160
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. bcl6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.
    Kawabata KC; Zong H; Meydan C; Wyman S; Wouters BJ; Sugita M; Goswami S; Albert M; Yip W; Roboz GJ; Chen Z; Delwel R; Carroll M; Mason CE; Melnick A; Guzman ML
    Blood; 2021 Feb; 137(6):812-825. PubMed ID: 32911532
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic analyses of early responses to radiation inglioblastoma reveal new alterations at transcription,splicing, and translation levels.
    Choudhary S; Burns SC; Mirsafian H; Li W; Vo DT; Qiao M; Lei X; Smith AD; Penalva LO
    Sci Rep; 2020 Jun; 10(1):8979. PubMed ID: 32488114
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography.
    Kim HO; Kim JS; Kim SO; Chae SY; Oh SJ; Seo M; Lee SH; Oh JS; Ryu JS; Huh JR; Kim JH
    Medicine (Baltimore); 2020 May; 99(20):e20140. PubMed ID: 32443328
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.